Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
56 words
An anti-thrombogenic blood treating system, comprising selectively permeable hollow yarn membranes made of a composition containing a copolymer with polyethylene oxide component, and headers, catheters and circuits respectively covered on the blood contact surface with a heparinized hydrophilic copolymer containing vinyl chloride as a component monomer or a hydrophilic copolymer with polyethylene oxide component, in combination.
Claim 2
Dependent Claim
28 words
An anti-thrombogenic blood treating system, according to claim 1, wherein the inner surfaces at the joints between the headers, catheters and circuits are free from any discrete protrusions.
Claim 3
Dependent Claim
59 words
An anti-thrombogenic blood treating system, according to claim 1, wherein the selectively permeable hollow yarn membranes are made of a composition containing a copolymer consisting of a monomer with a polyethylene oxide component of 5 or more in polymerization degree and a polymerizable carbon-carbon double bond in the same molecule and a monomer with a polymerizable carbon-carbon double bond.
Claim 4
Dependent Claim
47 words
An anti-thrombogenic catheter, with a catheter tube joined with a connector, comprising a layer of a heparinized hydrophilic copolymer containing vinyl chloride as a component monomer or a layer of a hydrophilic copolymer layer with polyethylene oxide component, being formed at least on its blood contact surface.
Claim 5
Dependent Claim
37 words
An anti-thrombogenic blood circuit, comprising a layer of a heparinized hydrophilic copolymer layer containing vinyl chloride as a component monomer or a layer of a hydrophilic copolymer with polyethylene oxide component, being formed on its inside surface.
Claim 6
Dependent Claim
35 words
An anti-thrombogenic header, comprising a layer of a heparinized hydrophilic copolymer containing vinyl chloride as a component monomer or a layer of a hydrophilic copolymer with polyethylene oxide component, being formed on its inside surface.
Claim 7
Dependent Claim
112 words
An anti-thrombogenic header, according to claim 6, wherein the header as a blood inlet port opened in the tangential direction of the inside space of the header; the height of the inside space on the inlet side is 1 to 5 times the inner diameter of the opened blood inlet port; the inner diameter of the inside space is larger than the outer diameter of a hollow yarn membrane bundle by 0 to 2 mm; the blood inlet port is in contact with the top of the inside space of the header; and the inside space has a conical protrusion at the center toward the opened end face of the hollow yarns.